Diagnostics for the developing world

Nature Reviews Microbiology

Volumn 2, Issue 3, 2004, Pages 231-240

  Mabey, David ^a   Peeling, Rosanna W ^b   Ustianowski, Andrew ^c   Perkins, Mark D ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELARSOPROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGGLUTINATION TEST; ANTIBODY DETECTION; ANTIGEN DETECTION; BACTERIUM CULTURE; BLOOD CULTURE; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FECES ANALYSIS; FECES CULTURE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; INTESTINE INFECTION; MALARIA; MORBIDITY; MORTALITY; NUCLEIC ACID AMPLIFICATION; PARASITOSIS; PATIENT COUNSELING; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; TRYPANOSOMIASIS; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; DIAGNOSTIC TESTS, ROUTINE; DIFFUSION OF INNOVATION; HUMANS; INFECTION CONTROL;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 3042576964     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro841     Document Type: Review

References (53)

1. Murray, C. J. L. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull. WHO 72 429-445 (1994).
2. Murray, C. J. L. & Lopez, A. D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 1269-1276 (1997).
3. World Bank World Development Report 1993: Investing in health. (Oxford Univ. Press, New York, 1993).
4. World Health Organization World Health Report 2002. [http://www.who.int/whr/2002/en/].
5. Espinal, M. A. et al. Global trends in resistance to anti-tuberculosis drugs. New Engl. J. Med. 344, 1294-1303 (2001).
6. Archibald, L. K. & Reller, L. B. Clinical microbiology resources in developing countries. Emerg. Infect. Dis. 7, 302-352 (2001).
7. Schloss, L. et al. An international external quality assessment of nucleic acid amplification of herpes simplex virus. J. Clin. Virol. 28, 175-185 (2003).
8. Suffys, P. et al. Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis. Int. J. Tuberc. Lung. Dis. 4, 179-183 (2000).
9. Noordhoek, G. T., van Embden, J. D. & Kolk, A. M. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J. Clin. Micribiol. 34, 2522-2525 (1996).
10. Mabey, D., Peeling, R. W. & Perkins, M. D. Rapid and simple point-of-care diagnostics for STIs. Sex. Tansm. Inf. 7, 397-3981 (2001).
11. Fears, M. B. & Pope, V. Syphilis Fast Latex agglutination test, a rapid confirmatory test. Clin. Diagn. Lab. Immunol. 8 841-842 (2001).
12. Gomez-Ochoa, P. et al. Modified direct agglutination test for simplified serologic diagnosis of leishmaniasis. Clin. Diagn. Lab. Immunol. 10, 967-968 (2003).
13. Boelaert, M. et al. Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis. Am. J. Trop. Med. Hyg. 60, 129-134 (1999).
14. Chandrasena, T. G., Premaratna, R., Abeyewickrema, W. & de Silva, N. R. Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka. Trans. R. Soc. Trop. Med. Hyg. 96, 60-63 (2002).
15. World Health Organization. Malaria Rapid Diagnosis - Making it Work. Informal consultation on field trials and quality assurance of malaria rapid diagnostic tests. WHO meeting report, 20-23 Jan 2003. [http://www.wpro.who.-int/rdt/docs/RDTs-MakingItWork.pdf].
16. Pate, M. S., Dixon, P. B., Hardy, K., Crosby, M. & Hook, E. W. Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic. J. Clin. Microbiol. 36, 2183-2186 (1998).
17. Widjaja, S. et al. Evaluation of a rapid assay for detection of Chlamydia trachomatis infections in outpatient clinics in South Kalimantan, Indonesia. J. Clin. Microbiol. 37, 4183-4185 (1999).
18. Cattand, P., Jannin, J. & Lucas, P. Sleeping sickness surveillance: an essential step towards elimination. Trop. Med. Int. Health. 6, 348-361 (2001).
19. Desjeux, P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14, 417-423 (1996).
20. Watson-Jones, D. et al. Syphilis and pregnancy outcomes in Tanzania. 1. Impact of maternal syphilis on outcome of pregnancy in Mwanza Region, Tanzania. J. Infect. Dis. 186, 940-947 (2002).
21. Terris-Prestholt, F. et al. Is antenatal syphilis screening still cost-effective in Sub-Saharan Africa? Sex. Tansm. Inf. 79, 375-381 (2003).
22. World Health Organization Child and Adolescent Health and Development Division. Integrated Management of Childhood Illness Information Pack. (World Health Organization, Geneva, 1998).
23. Wongsrichanalai, C., Pickard, A. L., Wernsdorfer, W. H. & Meshnick, S. R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2, 209-218 (2002).
24. Moody, A. Rapid diagnostic tests for malaria parasites. Clin. Microbiol. Rev. 15, 66-78 (2002).
25. Bell, D. Malaria rapid diagnostic tests: one size may not fit all. Clin. Microbiol. Rev. 15, 771-772 (2002).
26. Meheus, A. & Antal, G. M. The endemic treponematoses: not yet eradicated. World Health Stat. Q. 45, 228-237 (1992).
27. Gift, T. L., Pate, M. S., Hook, E. W. & Kassler, W. J. The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex. Transm. Dis. 26, 232-240 (1999).
28. Fraser, C. M. et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281, 375-388 (1998).
29. Stephens, R. S. et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754-759 (1998).
30. Cummings, C. A. & Relman, D. A. Using DNA microarrays to study host-microbe interactions. Emerging Infect. Dis. 8, 513-525 (2000).
31. Sasserath, J. N. & Fries, D. Developing microfluidics and bioMEMS. IVD Technology, June 2002. [http://www.devicelink.com/ivdt/archive/02/06/004.html].
32. DeLisa, M. P. et al. Evanescent wave long-period fiber bragg grating as an immobilized antibody biosensor. Anal. Chem. 72, 2895-2900 (2000).
33. Najera, J. A. Malaria control: achievements, problems and strategies. Parassitologia 43, 1-89 (2001).
34. Curtis, C. F. & Mnzava, A. E. Comparison of house spraying and insecticide-treated nets for malaria control. Bull. World Health Organ. 78, 1389-1400 (2000).
35. Guzman, M. G. & Kouri, G. Dengue: an update. Lancet Infect. Dis. 2, 33-42 (2002).
36. Schofield, C. J. & Dias, J. C. The Southern Cone Initiative against Chagas disease. Adv. Parasitol. 42, 1-27 (1999).
37. Pepin, J. & Meda, H. A. The epidemiology and control of human African trypanosomiasis. Adv. Parasitol. 49, 71-132 (2001).
38. Huttly, S. R., Morris, S. S. & Pisani, V. Prevention of diarrhoea in young children in developing countries. Bull. World Health Organ. 75, 163-174 (1997).
39. Drake, L. J. & Bundy, D. A. Multiple helminth infections in children: impact and control. Parasitology 122, S73-S81 (2001).
40. Seketeli, A. et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann. Trop. Med. Parasitol. 96 (Suppl. 1), S15-S28 (2002).
41. Ottesen, E. A. The global programme to eliminate lymphatic filariasis. Trop. Med. Int. Health 5, 591-594 (2000).
42. Magnussen, P. Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences. Acta Trop. 86, 243-254 (2003).
43. Changsong, S. et al. Achievement of the World Bank loan project an schistosomiasis control (1992-2000) in Hubei province and the challenge in the future. Acta Trop. 82, 169-174 (2002).
44. Olsen, A. Experience with school-based interventions against soil-transmitted helminths and extension of coverage to non-enrolled children. Acta Trop. 86, 255-266 (2003).
45. Mabey, D. C., Solomon, A. W. & Foster, A. Trachoma. Lancet 362, 223-229 (2003).
46. Schellenberg, D. et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 357, 1471-1477 (2001).
47. Geerligs, P. D., Brabin, B. J. & Eggelte, T. A. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull. World Health Organ. 81 205-216 (2003).
48. Pointier, J. P. & Jourdane, J. Biological control of the snail hosts of schistosomiasis in areas of low transmission: the example of the Caribbean area. Acta Trop. 77, 53-60 (2000).
49. Cairncross, S., Muller, R. & Zagaria, N. Dracunculiasis (guinea worm disease) and the eradication initiative. Clin. Microbiol. Rev. 15, 223-246 (2002).
50. Truc, P. et al. Evaluation of the micro-CATT, CATT/ Trypanosoma brucei gambiense, and LATEX/T. b. gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bull. World Health Organ. 80, 882-886 (2002).
51. Mondesire, R. R., Kozwich, D. L., Johansen, K. A., Gerdes, J. C. & Beard, S. E. Solid-phase nucleic acid extraction, amplification and detection. IVD Technology, May/June 2000. [http://www.devicelink.com/ivdt/archive/00/05/007.html].
52. Segondy, M. et al. Multicenter performance evaluation of NucliSens EasyQ HIV-1, European Clinical Microbiol. Infect. Dis. Conference, Abstract (Milan, Italy, 2002).
53. Laborde, R. T. & O'Farrell, B. Paramagnetic particle detection in a lateral flow assay. IVD Technology, Apr 2002. [http://www.devicelink.com/ivdt/archive/02/04/001.html].